Skip to main content

Dorsey Wright & Associates

SEC CIK
0001376772
Latest filing
Aug 6, 2026

VRDN holding history

Viridian Therapeutics, Inc. in every 13F filed by Dorsey Wright & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRDN overviewAll 13F holders of VRDNFull Q2 2026 holdings

Shares (Q2 2022)
0
Sold out in Q2 2022
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q1 2022
Holdings of VRDN by Dorsey Wright & Associates, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20220$00.0%−2,511−100.0%Sold outHolders
Q1 20222,511$46.0K<0.1%+2,511NewHolders